Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Multiple regulatory events contribute to a widespread circular RNA downregulation in precancer and early stage of colorectal cancer development

A. Camandona, A. Gagliardi, N. Licheri, S. Tarallo, G. Francescato, E. Budinska, M. Carnogurska, B. Zwinsová, B. Martinoglio, L. Franchitti, G. Gallo, S. Cutrupi, M. De Bortoli, B. Pardini, A. Naccarati, G. Ferrero

. 2025 ; 13 (1) : 30. [pub] 20250220

Status neindexováno Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25008390

Grantová podpora
825410 Horizon 2020
825410 Horizon 2020
825410 Horizon 2020
825410 Horizon 2020
825410 Horizon 2020
24882 Associazione Italiana per la Ricerca sul Cancro

BACKGROUND: Early detection of colorectal cancer (CRC) significantly improves its management and patients' survival. Circular RNAs (circRNAs) are peculiar covalently closed transcripts involved in gene expression modulation whose dysregulation has been extensively reported in CRC cells. However, little is known about their alterations in the early phases of colorectal carcinogenesis. METHODS: In this study, we performed an integrative analysis of circRNA profiles in RNA-sequencing (RNA-Seq) data of 96 colorectal cancers, 27 adenomas, and matched adjacent mucosa tissues. We also investigated the levels of cognate linear transcripts and those of regulating RNA-binding proteins (RBPs). Levels of circRNA-interacting microRNAs (miRNAs) were explored by integrating data of small RNA-Seq performed on the same samples. RESULTS: Our results revealed a significant dysregulation of 34 circRNAs (paired adj. p < 0.05), almost exclusively downregulated in tumor tissues and, prevalently, in early disease stages. This downregulation was associated with decreased expression of circRNA host genes and those encoding for RBPs involved in circRNA biogenesis, including NOVA1, RBMS3, and MBNL1. Guilt-by-association analysis showed that dysregulated circRNAs correlated with increased predicted activity of cell proliferation, DNA repair, and c-Myc signaling pathways. Functional analysis showed interactions among dysregulated circRNAs, RBPs, and miRNAs, which were supported by significant correlations among their expression levels. Findings were validated in independent cohorts and public datasets, and the downregulation of circLPAR1(2,3) and circLINC00632(5) was validated by ddPCR. CONCLUSIONS: These results support that multiple altered regulatory mechanisms may contribute to the reduction of circRNA levels that characterize early colorectal carcinogenesis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25008390
003      
CZ-PrNML
005      
20250422095748.0
007      
ta
008      
250408s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s40364-025-00744-8 $2 doi
035    __
$a (PubMed)39980011
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Camandona, Alessandro $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy
245    10
$a Multiple regulatory events contribute to a widespread circular RNA downregulation in precancer and early stage of colorectal cancer development / $c A. Camandona, A. Gagliardi, N. Licheri, S. Tarallo, G. Francescato, E. Budinska, M. Carnogurska, B. Zwinsová, B. Martinoglio, L. Franchitti, G. Gallo, S. Cutrupi, M. De Bortoli, B. Pardini, A. Naccarati, G. Ferrero
520    9_
$a BACKGROUND: Early detection of colorectal cancer (CRC) significantly improves its management and patients' survival. Circular RNAs (circRNAs) are peculiar covalently closed transcripts involved in gene expression modulation whose dysregulation has been extensively reported in CRC cells. However, little is known about their alterations in the early phases of colorectal carcinogenesis. METHODS: In this study, we performed an integrative analysis of circRNA profiles in RNA-sequencing (RNA-Seq) data of 96 colorectal cancers, 27 adenomas, and matched adjacent mucosa tissues. We also investigated the levels of cognate linear transcripts and those of regulating RNA-binding proteins (RBPs). Levels of circRNA-interacting microRNAs (miRNAs) were explored by integrating data of small RNA-Seq performed on the same samples. RESULTS: Our results revealed a significant dysregulation of 34 circRNAs (paired adj. p < 0.05), almost exclusively downregulated in tumor tissues and, prevalently, in early disease stages. This downregulation was associated with decreased expression of circRNA host genes and those encoding for RBPs involved in circRNA biogenesis, including NOVA1, RBMS3, and MBNL1. Guilt-by-association analysis showed that dysregulated circRNAs correlated with increased predicted activity of cell proliferation, DNA repair, and c-Myc signaling pathways. Functional analysis showed interactions among dysregulated circRNAs, RBPs, and miRNAs, which were supported by significant correlations among their expression levels. Findings were validated in independent cohorts and public datasets, and the downregulation of circLPAR1(2,3) and circLINC00632(5) was validated by ddPCR. CONCLUSIONS: These results support that multiple altered regulatory mechanisms may contribute to the reduction of circRNA levels that characterize early colorectal carcinogenesis.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gagliardi, Amedeo $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Turin, 10060, Italy $u Candiolo Cancer Institute, FPO IRCCS, Candiolo, Turin, 10060, Italy
700    1_
$a Licheri, Nicola $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy
700    1_
$a Tarallo, Sonia $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Turin, 10060, Italy $u Candiolo Cancer Institute, FPO IRCCS, Candiolo, Turin, 10060, Italy
700    1_
$a Francescato, Giulia $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Turin, 10060, Italy
700    1_
$a Budinska, Eva $u RECETOX, Faculty of Science, Masaryk University, Brno, 61137, Czech Republic
700    1_
$a Carnogurska, Martina $u RECETOX, Faculty of Science, Masaryk University, Brno, 61137, Czech Republic
700    1_
$a Zwinsová, Barbora $u RECETOX, Faculty of Science, Masaryk University, Brno, 61137, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, 62500, Czech Republic
700    1_
$a Martinoglio, Barbara $u Candiolo Cancer Institute, FPO IRCCS, Candiolo, Turin, 10060, Italy
700    1_
$a Franchitti, Lorenzo $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy
700    1_
$a Gallo, Gaetano $u Department of Surgery, "La Sapienza" University of Rome, Rome, 00161, Italy $u Department of Colorectal Surgery, Clinica S. Rita, Vercelli, 13100, Italy
700    1_
$a Cutrupi, Santina $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy
700    1_
$a De Bortoli, Michele $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy
700    1_
$a Pardini, Barbara $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Turin, 10060, Italy $u Candiolo Cancer Institute, FPO IRCCS, Candiolo, Turin, 10060, Italy
700    1_
$a Naccarati, Alessio $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Turin, 10060, Italy $u Candiolo Cancer Institute, FPO IRCCS, Candiolo, Turin, 10060, Italy
700    1_
$a Ferrero, Giulio $u Department of Clinical and Biological Sciences, University of Torino, Turin, 10100, Italy. giulio.ferrero@unito.it $u Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Turin, 10060, Italy. giulio.ferrero@unito.it
773    0_
$w MED00205975 $t Biomarker research $x 2050-7771 $g Roč. 13, č. 1 (2025), s. 30
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39980011 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250408 $b ABA008
991    __
$a 20250422095749 $b ABA008
999    __
$a ok $b bmc $g 2306361 $s 1245465
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2025 $b 13 $c 1 $d 30 $e 20250220 $i 2050-7771 $m Biomarker research $n Biomark Res $x MED00205975
GRA    __
$a 825410 $p Horizon 2020
GRA    __
$a 825410 $p Horizon 2020
GRA    __
$a 825410 $p Horizon 2020
GRA    __
$a 825410 $p Horizon 2020
GRA    __
$a 825410 $p Horizon 2020
GRA    __
$a 24882 $p Associazione Italiana per la Ricerca sul Cancro
LZP    __
$a Pubmed-20250408

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...